Search research articles
Contact Us
Filters
Showing results (321-330 of 358) with videos related to
Page
of 36
Sort By:
Liver International : Official Journal of the International Association for the Study of the Liver
|
January 26, 2025
Precision in Liver Diagnosis: Varied Accuracy Across Subgroups and the Need for Variable Thresholds in Diagnosis of MASLD
Yasaman Vali, Anne-Marieke van Dijk, Jenny Lee, et al.
Contemporary Clinical Trials
|
October 12, 2020
The European NAFLD Registry: A real-world longitudinal cohort study of nonalcoholic fatty liver disease
Timothy Hardy, Kristy Wonders, Ramy Younes, et al.
Journal of Hepatology
|
June 23, 2025
Impact of first and further decompensation in patients with compensated ACLD due to MASLD
Grazia Pennisi, Gabriele Di Maria, Vincent Wai-Sun Wong, et al.
Gut
|
January 10, 2024
Serum ferritin levels can predict long-term outcomes in patients with metabolic dysfunction-associated steatotic liver disease
Angelo Armandi, Tiziana Sanavia, Ramy Younes, et al.
Journal of Hepatology
|
April 12, 2020
A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement
Mohammed Eslam, Philip N Newsome, Shiv K Sarin, et al.
Hepatology Communications
|
November 23, 2021
Dysmetabolism, Diabetes and Clinical Outcomes in Patients Cured of Chronic Hepatitis C: A Real-Life Cohort Study
Luca Valenti, Serena Pelusi, Alessio Aghemo, et al.
Hepatology Communications
|
December 27, 2021
The rs429358 Locus in Apolipoprotein E Is Associated With Hepatocellular Carcinoma in Patients With Cirrhosis
Hamish Innes, Hans Dieter Nischalke, Indra Neil Guha, et al.
Nature Reviews. Gastroenterology & Hepatology
|
October 28, 2021
Advancing the global public health agenda for NAFLD: a consensus statement
Jeffrey V Lazarus, Henry E Mark, Quentin M Anstee, et al.
Cardiovascular Diabetology
|
July 25, 2024
MetSCORE: a molecular metric to evaluate the risk of metabolic syndrome based on serum NMR metabolomics
Rubén Gil-Redondo, Ricardo Conde, Chiara Bruzzone, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
October 6, 2023
Mechanisms by which the cystic fibrosis transmembrane conductance regulator may influence SARS-CoV-2 infection and COVID-19 disease severity
Philip R Tedbury, Candela Manfredi, Frauke Degenhardt, et al.
Page
of 36
Search research articles
Search
Showing results (321-330 of 358) with videos related to
Sort By:
Page
of 36
Liver International : Official Journal of the International Association for the Study of the Liver
|
January 26, 2025
Precision in Liver Diagnosis: Varied Accuracy Across Subgroups and the Need for Variable Thresholds in Diagnosis of MASLD
Yasaman Vali, Anne-Marieke van Dijk, Jenny Lee, et al.
Contemporary Clinical Trials
|
October 12, 2020
The European NAFLD Registry: A real-world longitudinal cohort study of nonalcoholic fatty liver disease
Timothy Hardy, Kristy Wonders, Ramy Younes, et al.
Journal of Hepatology
|
June 23, 2025
Impact of first and further decompensation in patients with compensated ACLD due to MASLD
Grazia Pennisi, Gabriele Di Maria, Vincent Wai-Sun Wong, et al.
Gut
|
January 10, 2024
Serum ferritin levels can predict long-term outcomes in patients with metabolic dysfunction-associated steatotic liver disease
Angelo Armandi, Tiziana Sanavia, Ramy Younes, et al.
Journal of Hepatology
|
April 12, 2020
A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement
Mohammed Eslam, Philip N Newsome, Shiv K Sarin, et al.
Hepatology Communications
|
November 23, 2021
Dysmetabolism, Diabetes and Clinical Outcomes in Patients Cured of Chronic Hepatitis C: A Real-Life Cohort Study
Luca Valenti, Serena Pelusi, Alessio Aghemo, et al.
Hepatology Communications
|
December 27, 2021
The rs429358 Locus in Apolipoprotein E Is Associated With Hepatocellular Carcinoma in Patients With Cirrhosis
Hamish Innes, Hans Dieter Nischalke, Indra Neil Guha, et al.
Nature Reviews. Gastroenterology & Hepatology
|
October 28, 2021
Advancing the global public health agenda for NAFLD: a consensus statement
Jeffrey V Lazarus, Henry E Mark, Quentin M Anstee, et al.
Cardiovascular Diabetology
|
July 25, 2024
MetSCORE: a molecular metric to evaluate the risk of metabolic syndrome based on serum NMR metabolomics
Rubén Gil-Redondo, Ricardo Conde, Chiara Bruzzone, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
October 6, 2023
Mechanisms by which the cystic fibrosis transmembrane conductance regulator may influence SARS-CoV-2 infection and COVID-19 disease severity
Philip R Tedbury, Candela Manfredi, Frauke Degenhardt, et al.
Page
of 36